285.4 📋 章末速記 Summary
285.4.1 🔑 一句話總結
主動脈瓣疾病分 AS(calcific 老年最常見、BAV 早發、rheumatic 全球漸減) + AR(chronic root dilation/BAV/IE healed; acute dissection/IE/trauma);AS 嚴重度:peak vel ≥ 4 + mean gradient ≥ 40 + AVA ≤ 1.0;症狀 SAD(syncope, angina, dyspnea)後 mortality 急升;2024 ACC/AHA + ESC: TAVR 已是所有 risk levels Class I (≥ 65 yo);EARLY-TAVR 2024 讓 asymptomatic severe AS 早期介入 Class IIa;Acute AR 是 emergency surgery,不可給 β-blocker / IABP。
285.4.2 💊 治療精要
- AS 醫療:無治癒藥物;統計治療 CV RF;diuretic 緩解 HF(小心 hypotension)
- AS 手術:TAVR(≥ 65 + all risk levels)vs SAVR(< 65、BAV、complex anatomy)
- AS asymptomatic severe:EARLY-TAVR 2024 → Class IIa;watchful waiting 可選
- chronic AR 醫療:ACEi/CCB 用於 symptomatic surgery 不適合者
- chronic AR 手術:症狀 / EF < 55% / LVESD > 50 mm(或 indexed > 25/m²)
- acute AR:emergency surgery;不要用 β-blocker、IABP
285.4.3 🎯 盧醫師的考前提醒
- AS severity 三要素:peak vel ≥ 4 m/s + mean gradient ≥ 40 + AVA ≤ 1.0 cm²
- AS 症狀 SAD 三聯:syncope (3 yr survival)、angina (5 yr)、dyspnea (2 yr) untreated
- dobutamine stress echo 是 low-flow low-gradient AS 鑑別工具:true vs pseudosevere vs no contractile reserve
- TAVR ≥ 65 yo, all risk levels (2024 ACC/AHA + ESC 共識);SAVR 仍適合 < 65、BAV、complex anatomy
- EARLY-TAVR 2024:asymptomatic severe AS(peak vel ≥ 4 m/s)→ early TAVR Class IIa(新里程碑)
- AR 手術指徵:symptoms / EF < 55% (Class I) / LVESD > 50 mm or > 25 mm/m² (Class I)
- acute AR = emergency:dissection、IE、trauma;β-blocker + IABP 禁忌(rely on tachy to maintain CO)
- AR 七大 eponyms:de Musset (head bob)、Müller (uvula)、Quincke (nail bed)、Traube (pistol shot)、Duroziez (femoral)、Hill (BP gap)、Austin Flint (apical rumble)、Becker (retinal)
- TAVR anticoag:ASA mono (POPular TAVI);避免 DOAC + ASA (GALILEO);AF 仍用 DOAC alone (ATLANTIS, ENVISAGE-TAVI AF)
- Lp(a)↑ 與 calcific AS 有關 — 未來治療標的(pelacarsen 等 Lp(a) 抑制劑)